Xeomin vs Botox: Pricing & Effectiveness Overview

If you want to boost your med spa’s bottom line with neurotoxins, the best move is to get smart about the xeomin vs botox decision. Here’s the answer up front: Both are strong options, both bring in steady revenue, and the choice depends on your market, patient mix, and how you run your business. But if you think through the differences in their formulas, pricing, and branding, you’ll make more money and serve your patients better.

Let’s break down exactly how these two injectables stack up so you can decide what to stock, how to talk about it with patients, and where you can save on supply costs.

Xeomin vs Botox: The Basics

Xeomin and Botox are both FDA-approved neurotoxin injectables. They both use botulinum toxin type A to treat wrinkles like forehead lines, frown lines, and crow’s feet. These are your bread-and-butter repeat treatments that keep people coming back.

• Botox has been around since 2002 and it’s the big name most patients recognize.
• Xeomin came on the scene in 2011 and is quickly catching up.

You’re not deciding between a good and a bad product here. Both do the job. But clinic owners who know the details tend to see healthier profits and happier patients.

Mechanisms of Action and Similarities

Both products work by using botulinum toxin type A to block nerve signals to facial muscles. This makes the muscles relax. The skin smooths out. Results last about three to four months, so patients need to come back a few times each year.

• Clinical studies show no real difference in safety or how well they work.
• Onset is usually between three to seven days. Full results kick in by day 14 for most patients.
• Both need about three to four treatments a year to keep results fresh.

To patients, there’s not much difference. The injector’s skill, right dose, and a patient’s metabolism play a much bigger role in results than the brand name on the vial.

Differences in Formulation and Manufacturing

Now, the science behind these injectables is where choices start to matter for your practice.

• Botox contains botulinum toxin plus accessory proteins that help stabilize the product.
• Xeomin has an extra purification step. It’s free of those accessory proteins. That’s why you’ll hear it called the “naked” neurotoxin.

Xeomin is the only FDA-approved neurotoxin that’s free of complexing proteins. Its molecular weight drops from around 900 kDa (Botox) to 150 kDa (Xeomin). That’s a big difference on the molecular level.

Here’s why it matters:

• Accessory proteins in Botox can trigger the immune system over time. This sometimes causes neutralizing antibodies to develop, which can cut effectiveness.
• Xeomin’s “clean” structure is less likely to cause this. In clinical trials, none of the 2,649 patients developed clinical resistance from neutralizing antibodies.
• If patients notice Botox isn’t working like it used to, Xeomin is a strong alternative.
• Xeomin is also stable at room temperature before reconstitution. Botox needs to stay cold. Xeomin gives you a bit more wiggle room for inventory and storage.

How Efficacy and Duration Compare

On a unit-to-unit basis, Xeomin and Botox work about the same. The dosing ratio is 1:1 for most treatment areas, which keeps switching easy for your team and your business math simple.

• Both products last 12 to 16 weeks for most cosmetic patients.
• Some say Xeomin might feel a bit shorter-acting at first, but this evens out after patients get regular maintenance.
• What matters more is the dose, injection site, and patient metabolism, not the brand.

In 2024, Xeomin became the first and only FDA-approved neurotoxin for treating all upper facial lines at once: forehead, frown, and crow’s feet. The total recommended dose is 64 units for a full upper face treatment. That’s a feature you can highlight in conversations and marketing.

Pricing Considerations for Your Med Spa

If you want solid margins on neurotoxins, nailing the price is key. Most practices aim to keep their cost of goods sold at 30 to 40% of revenue. That leaves room for profit. If costs drift higher, even a busy schedule will leave you underwhelmed by your bottom line.

• Botox commands higher prices, thanks to its name recognition. There’s value in that brand, and many patients ask for it by name.
• Xeomin is usually cheaper for you to buy wholesale, but just as effective. Your per-treatment margin can actually be better, especially if you take time to educate patients about its “cleaner” profile.
• Pricing changes by market. Average is about $18 per unit in California, closer to $12 in the Midwest. Know your local rates before setting prices.

Remember, your margin is the difference between what you pay and what you charge. Defend that gap. Many clinics offer both Botox and Xeomin so you can serve the “brand name” crowd and those who want a more purified option. This lets you help patients who lose Botox responsiveness over time, too.

How to Maximize Savings with Portrait

If you want to boost profits quickly, lower your wholesale neurotoxin cost. Small per-unit savings add up fast when you’re doing hundreds of injections every month. Portrait’s supply marketplace lets small clinics access big-chain prices on injectables and essentials, no long-term contracts, no revenue sharing.

• Some clinics save up to 60% on products like Xeomin and Botox.
• All the money you save stays in your practice.

Portrait also takes care of inventory. When you use a vial, the stock refreshes automatically and you get alerts if you’re running low. That keeps you from over-ordering or dealing with expired waste. Most clinics save 15 to 20% just by cutting waste.

The Rewards Program splits your savings between instant checkout discounts and rebate points. The more you order, the better your deal gets over time.

Portrait’s software handles everything, including scheduling, payments, patient records, inventory, and analytics. If you want help with marketing, compliance, or patient growth, it’s all included. It’s simple and saves you time.

Making the Most of Xeomin vs Botox for Your Clinic

There’s no single “best” answer for every clinic. Both Xeomin and Botox are strong products. Both bring back repeat patients. Both can be profitable if you keep sharp on pricing and costs.

• If you’re in a market where Botox is king, offer Xeomin as a premium purified option to patients who want or need something different.
• If you already carry Xeomin, double-check that you’re not paying too much for it. Watch your margins and leverage your volume for better rates.

Treat your supply costs like a priority. Wholesale prices shift. Your order volume will change. The clinics that track this and review their suppliers every quarter always come out ahead. When you buy more, ask for better deals.

Partner with platforms and vendors who fight for your bottom line, not just ship your orders. To learn more about the savings partnering with Portrait can deliver, book your intro call today.